APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 139 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,923 | -57.8% | 76,865 | +1.1% | 0.00% | -66.7% |
| Q2 2023 | $6,924 | +2977.3% | 76,011 | +2120.6% | 0.01% | – |
| Q1 2023 | $225 | -100.0% | 3,423 | -88.4% | 0.00% | -100.0% |
| Q3 2022 | $2,023,000 | +340.7% | 29,627 | +191.5% | 0.00% | – |
| Q2 2022 | $459,000 | +206.0% | 10,164 | +242.6% | 0.00% | – |
| Q1 2022 | $150,000 | – | 2,967 | +103.8% | 0.00% | – |
| Q4 2020 | $0 | – | 1,456 | -65.9% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 4,264 | -5.8% | 0.00% | – |
| Q2 2020 | $147,000 | -7.5% | 4,525 | -24.0% | 0.00% | – |
| Q1 2020 | $159,000 | +169.5% | 5,954 | +139.2% | 0.00% | – |
| Q3 2019 | $59,000 | +5800.0% | 2,489 | +3218.7% | 0.00% | – |
| Q2 2019 | $1,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |